Wolf-Henning Boehncke earned his M.D. as a fellow of the German Scholarship Foundation in Kiel/Germany and Glasgow/Great Britain. He received his postdoctoral training in immunology at the National Institutes of Health in Bethesda/USA. Following assignments at the University Hospitals in Kiel and Ulm he became Full Professor and Head of the Section of Allergy/Immunology at the Department of Dermatology of the Goethe-University in Frankfurt/Main. Since 2012, he is Head and Chairman of the Division of Dermatology and Venereology at the Geneva University Hospitals and Full Professor at the Department of Pathology and Immunology at the Faculty of Medicine of the University of Geneva.

Professor Boehncke has served in key positions of multiple national and international scientific organizations such as GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), IPC (International Psoriasis Council), and the German psoriasis registry PsoBest. Professor Boehncke is currently the president of SPIN (Skin Inflammation and Psoriasis International Network).

Professor Boehncke’s research focuses on clinical and translational projects in cutaneous inflammation. He has been Principal Investigator in multiple clinical studies of phases I - IV and published more than 500 peer-reviewed articles, among them landmark papers in The New England Journal of Medicine, The Lancet, Nature, and Nature Medicine. Several of these were honored by distinguished prizes.

In the last 5 years, Professor Boehncke has established a dedicated out-patient clinic for patients with chronic wounds, which in the meantime has become a point of reference on a national level. A large and rapidly increasing number of patients with a broad range of pathologies (chronic venous insufficiency, vasculitis, pyoderma gangraenosum, …) is seen and followed there. This substantial clinical activity is complemented by numerous research activities, including translational research on skin regeneration as well as clinical studies. One of the products of this activity is TrophiPatch, an allogeneic cellular skin patch developed by HekeTiss, a spin-off from the University of Geneva.